ArticleBioengineering & translational medicine2022

Targeted brain delivery of RVG29-modified rifampicin-loaded nanoparticles for Alzheimer's disease treatment and diagnosis.

Ruiyi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.